MiMedx Group, Inc. Cost of Revenue
MiMedx Group, Inc. (MDXG) reported Cost of Revenue of $19.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-29
- MiMedx Group, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $19.98M, a 6.96% increase year-over-year.
- MiMedx Group, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $17.37M, a 4.89% increase year-over-year.
- MiMedx Group, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $19.05M, a 12.69% increase year-over-year.
- MiMedx Group, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $18.72M, a 22.17% increase year-over-year.
- MiMedx Group, Inc. cost of goods and services sold for fiscal 2025 was $73.01M, a 21.54% increase from fiscal 2024.
- MiMedx Group, Inc. cost of goods and services sold for fiscal 2024 was $60.07M, a 9.96% increase from fiscal 2023.
- MiMedx Group, Inc. cost of goods and services sold for fiscal 2023 was $54.63M, a 13.08% increase from fiscal 2022.
- MiMedx Group, Inc. cost of goods and services sold for fiscal 2022 was $48.32M, a 21.92% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $19.98M 10-Q · filed 2026-07-29 | $37.35M 10-Q · filed 2026-07-29 | $56.40M derived: sum of 3 quarters · filed 2026-07-29 | $75.12M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $17.37M 10-Q · filed 2026-04-29 | $36.42M derived: sum of 2 quarters · filed 2026-04-29 | $55.14M derived: sum of 3 quarters · filed 2026-04-29 | $73.82M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $37.77M derived: sum of 2 quarters · filed 2026-02-25 | $56.45M derived: sum of 3 quarters · filed 2026-07-29 | $73.01M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $18.72M 10-Q · filed 2025-10-29 | $37.40M derived: sum of 2 quarters · filed 2026-07-29 | $53.96M 10-Q · filed 2025-10-29 | $70.87M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $18.68M 10-Q · filed 2026-07-29 | $35.24M 10-Q · filed 2026-07-29 | $52.15M derived: sum of 3 quarters · filed 2026-07-29 | $67.47M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $16.56M 10-Q · filed 2026-04-29 | $33.47M derived: sum of 2 quarters · filed 2026-04-29 | $48.79M derived: sum of 3 quarters · filed 2026-04-29 | $63.64M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $16.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $32.23M derived: sum of 2 quarters · filed 2026-02-25 | $47.09M derived: sum of 3 quarters · filed 2026-02-25 | $60.07M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $15.32M 10-Q · filed 2025-10-29 | $30.18M derived: sum of 2 quarters · filed 2025-10-29 | $43.16M 10-Q · filed 2025-10-29 | $57.01M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $14.86M 10-Q · filed 2025-07-30 | $27.84M 10-Q · filed 2025-07-30 | $41.68M derived: sum of 3 quarters · filed 2026-02-25 | $56.47M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $12.99M 10-Q · filed 2025-04-30 | $26.83M derived: sum of 2 quarters · filed 2026-02-25 | $41.62M derived: sum of 3 quarters · filed 2026-02-25 | $55.20M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.63M derived: sum of 2 quarters · filed 2026-02-25 | $42.22M derived: sum of 3 quarters · filed 2026-02-25 | $54.63M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $14.79M 10-Q · filed 2024-10-30 | $28.37M derived: sum of 2 quarters · filed 2024-10-30 | $40.79M 10-Q · filed 2024-10-30 | $55.16M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $13.58M 10-Q · filed 2024-07-31 | $26.00M 10-Q · filed 2024-07-31 | $40.37M derived: sum of 3 quarters · filed 2025-02-26 | $52.56M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $12.42M 10-Q · filed 2024-04-30 | $26.79M derived: sum of 2 quarters · filed 2025-02-26 | $38.98M derived: sum of 3 quarters · filed 2025-02-26 | $50.80M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $14.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $26.56M derived: sum of 2 quarters · filed 2025-02-26 | $38.38M derived: sum of 3 quarters · filed 2025-02-26 | $48.32M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $12.19M 10-Q · filed 2023-10-30 | $24.01M derived: sum of 2 quarters · filed 2023-10-30 | $33.95M 10-Q · filed 2023-10-30 | $41.05M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $11.82M 10-Q · filed 2023-08-01 | $21.76M 10-Q · filed 2023-08-01 | $28.86M derived: sum of 3 quarters · filed 2024-02-28 | $38.99M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $9.94M 10-Q · filed 2023-05-02 | $17.03M derived: sum of 2 quarters · filed 2024-02-28 | $27.16M derived: sum of 3 quarters · filed 2024-02-28 | $39.92M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $17.23M derived: sum of 2 quarters · filed 2024-02-28 | $29.99M derived: sum of 3 quarters · filed 2024-02-28 | $39.63M 10-K · filed 2024-02-28 | $43.28M 10-K · filed 2022-02-28 |
| 2021-09-30 | $10.13M 10-Q · filed 2022-11-02 | $22.89M derived: sum of 2 quarters · filed 2022-11-02 | $32.53M 10-Q · filed 2022-11-02 | $43.35M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $12.76M 10-Q · filed 2022-08-02 | $22.40M 10-Q · filed 2022-08-02 | $33.22M derived: sum of 3 quarters · filed 2023-02-28 | $43.51M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $9.64M 10-Q · filed 2022-05-03 | $20.46M derived: sum of 2 quarters · filed 2023-02-28 | $30.75M derived: sum of 3 quarters · filed 2023-02-28 | $38.95M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $21.11M derived: sum of 2 quarters · filed 2023-02-28 | $29.30M derived: sum of 3 quarters · filed 2023-02-28 | $39.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $10.29M 10-Q · filed 2021-11-02 | $18.49M derived: sum of 2 quarters · filed 2021-11-02 | $28.51M 10-Q · filed 2021-11-02 | $41.22M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $8.20M 10-Q · filed 2021-08-03 | $18.22M 10-Q · filed 2021-08-03 | $30.93M derived: sum of 3 quarters · filed 2022-02-28 | $44.14M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $10.03M 10-Q · filed 2021-04-28 | $22.73M derived: sum of 2 quarters · filed 2022-02-28 | $35.94M derived: sum of 3 quarters · filed 2022-02-28 | $45.69M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $25.91M derived: sum of 2 quarters · filed 2022-02-28 | $35.66M derived: sum of 3 quarters · filed 2022-02-28 | $43.08M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $13.21M 10-Q · filed 2020-11-04 | $22.95M derived: sum of 2 quarters · filed 2020-11-04 | $30.37M 10-Q · filed 2020-11-04 | $40.77M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2019-06-30 | $9.75M 10-Q · filed 2020-08-04 | $17.17M 10-Q · filed 2020-08-04 | $27.57M derived: sum of 3 quarters · filed 2021-03-08 | $34.92M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2019-03-31 | $7.42M 10-Q · filed 2020-07-06 | $17.82M derived: sum of 2 quarters · filed 2021-03-08 | $25.18M derived: sum of 3 quarters · filed 2021-03-08 | $34.45M derived: sum of 4 quarters · filed 2021-03-08 | |
| 2018-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $17.76M derived: sum of 2 quarters · filed 2021-03-08 | $27.03M derived: sum of 3 quarters · filed 2021-03-08 | $36.39M 10-K · filed 2021-03-08 | |
| 2018-09-30 | $7.36M 10-Q · filed 2020-07-06 | $16.63M derived: sum of 2 quarters · filed 2020-07-06 | $25.98M 10-Q · filed 2020-07-06 | ||
| 2018-06-30 | $9.27M 10-Q · filed 2020-07-06 | $18.63M 10-Q · filed 2020-07-06 | |||
| 2018-03-31 | $9.36M 10-Q · filed 2020-07-06 | ||||
| 2017-12-31 | $35.22M 10-K · filed 2020-07-06 | ||||
| 2016-12-31 | $30.94M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |